PD-1 Inhibitors in the Advanced Esophageal Cancer.

Front Pharmacol · 2019 · PMC6916418 · PMID 31920637

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Although relative a small sample, a clear trend could be easily found favoring the former, with elevated ORRs, prolonged PFS and OS, and less frequency of any-grade or grade 3–5 AE in immunotherapy.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.